#All AIIMS | Explore Tumblr posts and blogs

sabbathbloodysabbeth · 1 year ago

Text

"Hey There, Dio"

July 2023 prompt "pool" / 442 words / rated g / tw; Eddie is drunk (don't know if that counts as a trigger) / @steddiemicrofic

Steve glances over the pool table, watching dark curls fall in front of the other man's face. Tattoos stretched out on his skin as he moves his arms out while holding the cue stick aiimed at a dark green ball. Steve lets a soft chuckle rip through his chest when he realizes the guy doesn’t know what he’s doing. Either that or he was too drunk to realize his mistake.

“Hey there Dio, you're supposed to hit the white ball into the striped balls.” Steve comments amused as he holds the stick against his chest. Snorting as he watches the other drunkenly move around the table to the white ball.

“I knew that.”

“Sure you did, pal.”

Steve shakes his head as his eyes land on the Dio patch on the other’s vest. Tracing the details on the image as he waits for the other to hit the ball. Which never comes as the guy misses and falls face-first into the baize. It was absolutely pathetic and Steve forces himself to hold his laughter back. Not understanding why the other was so determined to play a match with him if he was to wasted to see straight.

Instead of teasing the other like he wanted to, he moves and wraps his arm around the others waist. Sliding his arm underneath the leather jacket as he pulls the others arm around his shoulder so he could help him walk.

“Oooooh, gotta buy me a drink first big boy,” The flirting is new and it causes Steves brain to shortwire with confusion. He did walk in a straight bar right?

“Well good thing waters free then.” Steve says amused. He doesn’t know who this guy was but he was determined to make sure he was safe for the night.

“Noooo, not water.” The man tosses his head back almost causing both of them to flop back onto the pool table. Steve grunts a little at the amount of weight he has to lift before he gets a better grip on the other to help him walk over to a booth. Being dragged down to sit next to the orher as the man tosses his legs over his lap. Tilting his head a bit, before moving forward and licking the side of Steve’s face.

“Finder Keepers.”

Steve's face scrunches up a bit as he tries to lift his hand up and wipe the spit off from his face. Trying his hardest to be mad at the other whose eyes have grown wide all of a sudden.

“You’s the most prettiest boy I ever met.”

And oh god tonight, was going to be a long night.

158 notes · View notes

covid-safer-hotties · 1 month ago

Text

Also preserved in our archive

Another great reason to keep masking: We don't even have a good treatment for long covid yet, and many doctors know simply nothing about the condition.

Global efforts to understand and manage long Covid post-pandemic, with varied symptoms and limited treatment guidelines worldwide

Doctors in India are grappling to diagnose and treat unexplained and persistent symptoms of long Covid patients due to limited guidelines, whereas researchers have flagged inadequate studies on the condition.

With the World Health Organization declaring an end to COVID-19 as a global health emergency in May last year, focused efforts are underway around the world to estimate the burden of long Covid among the population.

The condition refers to the set of lingering symptoms affecting varied body parts and persisting well beyond the acute Covid infection period, including cough, muscle and joint pain, fatigue, brain fog and difficulty in focusing. The viral disease is caused by the SARS-CoV-2 virus.

While studies have suggested that about a third of those moderately or severely infected are likely to suffer from long Covid, region-wise though, incidence could vary.

A study by researchers, including those from Harvard Medical School, U.S., estimated that 31% of the once-infected people in North America, 44% in Europe, and 51% in Asia, have long Covid, which is “challenging the healthcare system, but there are limited guidelines for its treatment”. It was published in the International Journal of Infectious Diseases in September.

In India, however, studies on long Covid are few and far between.

One such study by Maulana Azad Medical College in New Delhi, conducted from May 2022 to March 2023 on 553 patients who had recovered from Covid, found that about 45% had lingering symptoms, persistent fatigue and dry cough being the most common.

“There is limited exploratory research on the long Covid syndrome with scarce data on long-term outcomes,” the authors wrote in the study published in the journal Cureus in May this year.

Understanding the long-term effects of the virus is important for developing management strategies, optimising healthcare delivery, and providing support to recovered Covid patients in the community, they said.

Dr Rajesh Sagar, Professor of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, said, “Looking at the current state of long Covid studies in India, it is too premature to say that we understand the condition well enough to know how to diagnose or treat it.”

Animesh Samanta, assistant professor at School of Natural Sciences in Shiv Nadar University, Greater Noida, said, “While studies in India highlight the growing recognition of neurological complications in long Covid patients, more focused research on neuroinflammation is needed.”

Doctors, too, have reported a rise in patients complaining of symptoms that they did not have pre-Covid. “People who never had asthma in the past, post-Covid, with every viral infection, they get a long cough, shortness of breath and wheezing, which require the use of inhalers or nebuliser,” senior consultant Dr. Neetu Jain, who runs a post-Covid care clinic at Pushpawati Singhania Hospital and Research Institute, New Delhi, said.

Dr. Arun Garg, chairman, Neurology and Neurosciences, Medanta-The Medicity, Gurugram, said that he was noticing a spike in stroke cases among young patients not suffering from known risk factors such as diabetes, hypertension and obesity.

“Similarly, we are seeing more cases of encephalopathy (swelling of the brain) without reason and having a confused state of mind following one or two days of fever. Their MRI scans show no changes. These patients have increased significantly after Covid,” he said.

In the absence of medical guidelines to diagnose long Covid, doctors are having to resort to broad, non-specific tests and questionnaires to gauge a patient’s ‘quality of life’.

Studies have shown that the fatigue experienced in long Covid is similar to that in cancer patients, with a quality of life similar to patients of Parkinson’s disease.

“We really do not have any test to diagnose long Covid, even though it is definitely a clinical diagnosis. We diagnose long Covid for people who had at least moderate to severe infection, following which they could never regain the quality-of-life pre-Covid. Checking for inflammatory markers like C-reactive proteins (CRP) can support the diagnosis,” Dr. Jain said.

“Other than routine blood tests that measure inflammation, we do antibody tests to look for direct markers. In many of these patients, we are finding rare antibodies which are very new to us and were not there pre-Covid,” Dr. Garg said.

Inflammation persisting despite recovery from acute Covid infection is thought to lie at the heart of long Covid. However, tests to measure this specific immune response are lacking, even as researchers have been working in this direction worldwide.

One such effort comes from Shiv Nadar University, where a team led by Mr. Samanta has developed a fluorescent probe capable of detecting inflammation in brain cells that can arise due to Covid infection.

The probe measures nitric oxide levels in brain cells, especially in human microglia cells, where increased NO levels are linked to the SARS-CoV-2 infection. Microglia are immune cells in the brain that fight disease and help maintain brain health.

Lysosomes within microglia, which help clear foreign disease-causing agents like the SARS-CoV-2 virus, produce nitric oxide as part of an immune response to infection. The probe detects nitric oxide produced in lysosomes in response to infection and thereby allows for a measurement of inflammation levels.

This examination method can provide “qualitative information on infection status”, said Mr. Samanta, corresponding author on the study published in the journal Analytical Chemistry in American Chemical Society.

He explained that patients with pre-existing conditions such as Alzheimer’s disease, Parkinson’s disease or multiple sclerosis (an autoimmune disorder) could exhibit prolonged neuroinflammation and loss of brain cells following Covid infection.

While the probe has shown efficacy in cell cultures, animal studies would need to be done, before testing it in humans, Mr. Samanta said.

Looking at the World Health Organization International Clinical Trials Registry Platform, the study by Harvard Medical School had found that 587 clinical studies were conducted on long Covid, of which about 53% (312) were testing potential treatments.

Most of these were found to be conducted in the U.S. (58), followed by India (55) and Spain (20). The trials looked at interventions including physical exercise, psychotherapy, and pharmacological ones such as paxlovid and fluvoxamine.

However, “to date, only 11 of these 312 studies have published their results that were not confirmative,” the researchers wrote.

The team called for studies to look into sleep disorders which were rarely included in the registered clinical studies. Further, interventions targeting the biological processes responsible for long Covid are needed but currently lacking, they said.

#mask up #covid #pandemic #public health #wear a mask #covid 19 #wear a respirator #still coviding #coronavirus #sars cov 2 #long covid #india

12 notes · View notes

mediagraph · 4 months ago

Text

'No Safety, No Duty': OPD Services Hit By Nationwide Doctors' Protest

Doctors across the country have refused to return to work, except for emergency procedures, as they protest against the rape and murder of a 31-year-old doctor at Kolkata's RG Kar Medical College and Hospital. Nationwide protests are underway

The Federation of Resident Doctors' Association (FORDA) yesterday announced a nationwide pause in elective services in hospitals. In a letter to Union Health Minister JP Nadda, FORDA described the Kolkata incident as "perhaps the greatest travesty to have occurred in the history of the resident doctor community".

FORDA has demanded resignation of all authorities concerned who could not protect the dignity and life of a woman on-duty doctor. They have also sought an assurance that the protesting doctors will not be manhandled and swift action in the case.

Treatment at most hospitals in Kolkata has taken a hit after doctors joined the protest demanding justice in the case. Several patients and their relatives have complained of inconvenience due to the protest.

The number of daily surgeries at AIIMS Delhi are down by 80 per cent and admissions by 35 per cent after doctors began an indefinite strike over the Kolkata incident, news agency PTI has reported. AIIMS authorities have, meanwhile, issued a circular, asking the doctors to join work and citing a High Court order that doctors cannot be part of protests on the premises.

The Indian Medical Association (IMA) has shot off a letter to Health Minister Nadda, demanding the enactment of a central law to curb attacks and violence against doctors as a "deterrence" measure and declaration of hospitals as safe zones.

A civic volunteer who frequented the hospital has been arrested in connection with the rape and murder of the Kolkata doctor. West Bengal Chief Minister has given city police time till Sunday to complete the probe, after which the state government will recommend a CBI investigation.

#FORDA #AIIMS #RG kar Medical College

17 notes · View notes

scarlet-sam-chaos · 3 months ago

Text

me being delulu and adding every single one of the 26 aiims and both of the jipmers and all of the mumbai and delhi gmcs in my mcc preference list while knowing i won't get a single one of them be like: 🤡

#desiblr #desi tumblr #desi tag #desi shit posting #neet2024 #neetexam #neet 2024 #fuck nta #scarlet rambles

8 notes · View notes

incoherentscreaming101 · 6 months ago

Text

suffering for two fucking years going from school to coaching and home and mental health being completely wreaked in the two years and finally giving neet 2024 not caring that im not going to get a medical seat with my marks and finally trying to get my passions back to finding out that NTA has fucked all students just plain hurts.

like sure i personally dont care that im not getting a seat in a medical college but for all the blood sweat tears and suffering that i still put in for my family's sake i was finally rewarded with the authorities completely fucking up.

and like, im a human, a student who has been fucked by NTA so i can empathise with people who got 600+ and still are not going to get a seat. I can try and understand the pain of people who got 720 and may not get aiims delhi

idk how to articulate my words rn all i feel is a huge sense of betrayal from the fucking education system

fuck you NTA

#marks se zyada hurt kiya education system ka fuck up #nta #neet 2024 #neet exam #desiblr

11 notes · View notes

bbmct · 8 days ago

Text

Start Your Breakthrough Clinical Trials At AIIMS Hospital With BBMCT

Clinical trials are the backbone of medical advancements, helping researchers and healthcare professionals find new treatments, therapies, and solutions to pressing health issues. In India, AIIMS (All India Institute of Medical Sciences) has long been at the forefront of healthcare excellence, and when combined with **British Biomedicine Clinical Trials (BBMCT)**, it offers world-class research facilities and clinical expertise for cutting-edge breakthroughs. In this article, we’ll explore how BBMCT at AIIMS provides unmatched support for clinical research and trials.

— -

### **World-Class Research Facilities Available**

AIIMS Hospital is renowned globally for its state-of-the-art research infrastructure. The research facilities at AIIMS are designed to cater to diverse medical specialties, making it an ideal location for conducting advanced clinical trials. The hospital’s vast campus houses modern laboratories, research centers, and equipment, all of which are equipped with the latest technology to support clinical research.

British Biomedicine Clinical Trials (BBMCT) leverages these facilities to create an environment where studies can progress smoothly and efficiently. Whether it’s pharmacokinetics, bioequivalence studies, or clinical pharmacology trials, BBMCT at AIIMS offers a comprehensive setup for all kinds of advanced research. This enables researchers to gather precise data, ensuring faster and more accurate results.

— -

### **Expert Clinical Trials Management Team**

The success of clinical trials depends largely on the expertise and experience of the team managing them. BBMCT at AIIMS boasts an experienced team of medical professionals, researchers, and trial coordinators who specialize in clinical research and trial management. This team oversees every aspect of the clinical trial process, from initial planning to the final data analysis.

The clinical trial management team at BBMCT follows international best practices in Good Clinical Practice (GCP), ensuring that all trials meet rigorous scientific and ethical standards. Their profound knowledge in regulatory compliance, patient safety, and data integrity is a key asset for any study looking to achieve reliable and actionable results.

— -

### **Access to Diverse Patient Populations**

A unique advantage of conducting clinical trials at AIIMS is the access to a highly diverse patient population. AIIMS caters to patients from various socio-economic backgrounds, ethnicities, and regions. This diversity enhances the generalizability and relevance of clinical trial outcomes, ensuring that findings are applicable to a broad spectrum of people.

BBMCT at AIIMS takes full advantage of this diverse patient pool, allowing researchers to study the effects of treatments on a wide range of individuals. This helps researchers to detect varying responses to interventions, ensuring that the clinical trial results are robust, representative, and suitable for global healthcare applications.

— -

### **Cutting-Edge Technology Integration Offered**

To stay ahead in the fast-paced world of clinical trials, BBMCT integrates the latest technological advancements in clinical research at AIIMS. From electronic data capture (EDC) systems to cloud-based analytics platforms, AIIMS and BBMCT are fully equipped with cutting-edge technologies that streamline trial processes and improve accuracy.

These technologies enable real-time monitoring of trial data, faster recruitment and retention of participants, and more efficient management of study documentation. Furthermore, AIIMS is constantly upgrading its infrastructure to incorporate new innovations, ensuring that trials benefit from the most advanced tools available in medical research.

— -

### **Robust Ethical Oversight Ensured Here**

Clinical trials often involve testing new treatments on human participants, making ethical oversight a critical part of the research process. At AIIMS, ethical considerations are a top priority. BBMCT ensures that all clinical trials are conducted in accordance with the highest ethical standards, including patient informed consent, confidentiality, and protection from harm.

AIIMS has a dedicated ethics committee that reviews and monitors each clinical trial to ensure compliance with national and international ethical guidelines. This oversight gives patients confidence in participating and reassures researchers that their trials are conducted responsibly, ensuring the integrity and credibility of the results.

— -

### **Collaborate With Leading Medical Experts**

When conducting clinical research at AIIMS with BBMCT, you gain access to some of the leading medical experts in various fields. AIIMS is home to renowned specialists and researchers across disciplines, including oncology, cardiology, neurology, and infectious diseases.

Collaborating with these experts not only enhances the quality of research but also allows for interdisciplinary approaches to clinical trials. BBMCT fosters an environment of collaboration, where your study can benefit from the expertise and innovative solutions provided by these thought leaders in medicine and clinical research.

— -

### **Streamlined Processes for Quick Trials**

The faster clinical trials progress, the sooner medical breakthroughs can be made. At BBMCT, the processes involved in clinical trials are streamlined to reduce unnecessary delays and inefficiencies. From patient recruitment to data collection and analysis, BBMCT ensures that every phase of the trial is executed promptly.

AIIMS’ established infrastructure and resources facilitate quick approvals, recruitment, and trial management, meaning that studies can progress without the common bottlenecks seen in other settings. This streamlined approach is critical in accelerating the development of new treatments and improving patient outcomes.

— -

### **Enhance Your Study’s Success Rates**

Clinical trials require precision, efficiency, and an in-depth understanding of the research process. BBMCT at AIIMS is dedicated to enhancing the success rates of studies by offering the right resources, expertise, and infrastructure. With world-class facilities, expert teams, and cutting-edge technology, BBMCT ensures that trials are conducted optimally and that every potential challenge is mitigated.

The strategic support provided by BBMCT helps in better trial design, data accuracy, and recruitment strategies, which ultimately increase the likelihood of achieving positive study outcomes. Whether you are testing a new drug or a medical device, BBMCT maximizes your study’s chances of success.

/media/4ba4cf5bfd511c0ae4ae8e305b8459ec

— -

### **Frequently Asked Questions (FAQs)**

**1. What makes BBMCT at AIIMS different from other clinical trial organizations?**

BBMCT at AIIMS offers a combination of world-class research facilities, access to diverse patient populations, and expert clinical trial management. The integration of cutting-edge technologies and robust ethical oversight ensures that clinical trials are conducted efficiently and ethically. Additionally, AIIMS’ reputation and access to leading medical experts make BBMCT a standout choice for clinical research in India.

**2. How does AIIMS ensure ethical oversight during clinical trials?**

AIIMS has a dedicated ethics committee that reviews all clinical trials before they begin. The committee ensures that the trials adhere to national and international ethical standards, protecting the rights and well-being of participants. Informed consent, privacy, and safety protocols are central to their oversight, making sure trials are conducted responsibly.

**3. Can international researchers collaborate with BBMCT at AIIMS?**

Yes, BBMCT encourages international collaboration. Researchers from across the globe can partner with AIIMS and benefit from its vast resources, medical expertise, and advanced research facilities. International collaboration is particularly valuable in improving the scope and impact of clinical trials by incorporating diverse perspectives and expertise.

**4. What patient populations can BBMCT at AIIMS access for clinical trials?**

AIIMS serves a diverse patient population from various socio-economic backgrounds and regions. This diversity allows researchers to assess the effectiveness of treatments on a broad spectrum of individuals, increasing the relevance and applicability of study outcomes. BBMCT ensures that clinical trials can tap into this wide variety of patient groups for robust data collection.

**5. How do BBMCT’s cutting-edge technologies improve clinical trials?**

BBMCT integrates advanced technologies like electronic data capture, real-time monitoring systems, and cloud-based analytics to streamline trial processes. These technologies improve the accuracy of data, reduce trial delays, and enhance participant management. The use of such tools also accelerates the trial timeline, ensuring faster results and quicker access to new treatments.

— -

### **Conclusion**

AIIMS Hospital, in partnership with **British Biomedicine Clinical Trials (BBMCT)**, offers one of the most advanced environments for clinical research in the world. With world-class research facilities, an expert clinical trials management team, and a commitment to ethical oversight, BBMCT ensures that each clinical trial conducted at AIIMS is a step towards scientific breakthroughs and improved patient care. The integration of cutting-edge technology and access to diverse patient populations further enhances the success rates of trials, ensuring that medical innovations reach the people who need them most. If you are looking to advance your clinical research, starting your breakthrough trials with BBMCT at AIIMS is a choice you can trust.

Subscribe to BBMCLINICALTRIALS YouTube channel for Research Insights

Be sure to subscribe to the **BBMCLINICALTRIALS YouTube channel** for exclusive access to the latest updates and in-depth insights into British Biomedicine Clinical Trials (BBMCT). Stay informed on cutting-edge research, clinical trial advancements, patient safety protocols, and breakthrough therapies being tested at AIIMS Hospital. Our channel provides expert discussions, industry trends, and detailed videos on the clinical trial process across various therapeutic areas. Whether you’re a healthcare professional, researcher, or simply interested in biomedical innovation, subscribing will keep you at the forefront of clinical research developments. Don’t miss out — join our community today!

#anya mouthwashing #batman #artists on tumblr #agatha harkness #captain curly #cats of tumblr #bucktommy #agatha all along #911 abc

4 notes · View notes